<DOC>
	<DOCNO>NCT02834169</DOCNO>
	<brief_summary>Despite advance management change clinical practice , little known epidemiology , pattern care outcome rare peritoneal surface malignancy patient France . In order well understand characteristic rare peritoneal surface malignancy evaluate treatment strategy , RENAPE registry aim collection data patient present rare peritoneal surface malignancy France . Data enter prospectively specifically design secure web database . All RENAPE 's centre physician invited register patient rare peritoneal surface malignancy diagnosis participate registry . Data evaluate within regular time frame , focus type rare peritoneal surface malignancy , treatment modality patient outcome ( e.g . survival , recurrence ) , thereby contribute well understand rare cancer .</brief_summary>
	<brief_title>French National Registry Rare Peritoneal Surface Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cystadenocarcinoma , Serous</mesh_term>
	<mesh_term>Desmoplastic Small Round Cell Tumor</mesh_term>
	<mesh_term>Pseudomyxoma Peritonei</mesh_term>
	<mesh_term>Leiomyomatosis</mesh_term>
	<criteria>Patients eligible histologically proven rare peritoneal surface malignancy . Histological diagnostic peritoneal surface malignancy confirm Expected clinical follow data available</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Rare peritoneal surface malignancy</keyword>
	<keyword>pseudomyxoma peritonei</keyword>
	<keyword>peritoneal mesothelioma</keyword>
	<keyword>desmoplastic small round cell tumor</keyword>
	<keyword>psammocarcinoma</keyword>
	<keyword>primary peritoneal serous carcinoma</keyword>
	<keyword>diffuse peritoneal leiomyomatosis</keyword>
	<keyword>appendiceal mucinous neoplasm</keyword>
	<keyword>registry</keyword>
	<keyword>population-based database</keyword>
</DOC>